LEQSELVI vs RINVOQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. LEQSELVI and RINVOQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LEQSELVI	RINVOQ
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DEURUXOLITINIB PHOSPHATE	UPADACITINIB
Manufacturer	Sun Pharm Inds Inc	Abbvie
Dosage forms	Tablet	Solution, Tablet, extended release
Drug class	Janus Kinase Inhibitor	Janus Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Half-life	—	about 8 to 14 hours (mean terminal elimination half-life)
Treats	Alopecia Areata	Rheumatoid Arthritis

leqselvi rinvoq

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

DEURUXOLITINIB PHOSPHATE

UPADACITINIB

Manufacturer

Sun Pharm Inds Inc

Abbvie

Dosage forms

Tablet

Solution, Tablet, extended release

Drug class

Janus Kinase Inhibitor

Boxed warning

Half-life

—

about 8 to 14 hours (mean terminal elimination half-life)

Treats

Alopecia Areata

Rheumatoid Arthritis

Frequently asked questions

What is the difference between Leqselvi and Rinvoq?

Leqselvi contains Deuruxolitinib Phosphate, while Rinvoq contains Upadacitinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.